Spice: A never ending story?

被引:243
作者
Lindigkeit, Rainer [1 ]
Boehme, Anja [1 ]
Eiserloh, Ina [1 ]
Luebbecke, Maike [1 ]
Wiggermann, Marion [1 ]
Ernst, Ludger [2 ]
Beuerle, Till [1 ]
机构
[1] Braunschweig Univ Technol, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany
[2] Braunschweig Univ Technol, Dept Chem, Cent NMR Lab, D-38106 Braunschweig, Germany
关键词
Spice; CP 47,497-C8; JWH-018; Cannabimimetic; Alkylaminoindole; GC-MS; CANNABIMIMETIC INDOLES; CANNABINOID RECEPTOR; IDENTIFICATION; CB1;
D O I
10.1016/j.forsciint.2009.06.008
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
On January 22nd 2009, the German Health Authorities prohibited several non-traditional cannabinoids, that proved to be the active components in popular "Bio-Designer-Drugs" like "Spice" and analogous products. The recent detection of CP 47,497-C8 in Europe and Japan documents that these products have already spread world wide. We synthesized several potentially interesting alkylaminoindoles (alkylchain C-3 to C-7) and isolated CP 47,497-C8 from "Spice Gold". The compounds were purified and characterized by NMR and mass spectrometry methods. With the aid of these authentic references we were able to detect and quantify added psychoactive compounds in different herbal blends. All samples that were acquired before the prohibition in December 2008 contained either CP 47,497-C8 (5.4-11.0 mg/g) or JWH-01 8 (2.3 mg/g). Some samples acquired in March 2009, 4 weeks after the prohibition took place, still contained CP 47,497-C8 (3.0-3.3 mg/g) but JWH-018 was not detected anymore. Instead it was replaced by its non-regulated C-4-homolog JWH-073 (5.8-22.9 mg/g). Furthermore some of the new products did not contain any non-traditional cannabinoids. To our knowledge this is the first report of the appearance JWH-073 as a new designer drug. The data and method presented here will facilitate and accelerate the detection of these compounds in complex matrices. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:58 / 63
页数:6
相关论文
共 12 条
[1]   Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding [J].
Aung, MM ;
Griffin, G ;
Huffman, JW ;
Wu, MJ ;
Keel, C ;
Yang, B ;
Showalter, VM ;
Abood, ME ;
Martin, BR .
DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) :133-140
[2]   'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? [J].
Auwaerter, Volker ;
Dresen, Sebastian ;
Weinmann, Wolfgang ;
Mueller, Michael ;
Puetz, Michael ;
Ferreiros, Nerea .
JOURNAL OF MASS SPECTROMETRY, 2009, 44 (05) :832-837
[3]  
COMPTON DR, 1992, J PHARMACOL EXP THER, V260, P201
[4]   Retention index expressions [J].
Ettre, LS .
CHROMATOGRAPHIA, 2003, 58 (7-8) :491-494
[5]  
HERBERT F, 1965, TERMINOLOGY IMPERIUM
[6]   1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles [J].
Huffman, JW ;
Szklennik, PV ;
Almond, A ;
Bushell, K ;
Selley, DE ;
He, HJ ;
Cassidy, MP ;
Wiley, JL ;
Martin, BR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (18) :4110-4113
[7]   3-indolyl-1-naphthylmethanes:: New cannabimimetic Indoles provide evidence for aromatic stacking interactions with the CB1 cannabinoid receptor [J].
Huffman, JW ;
Mabon, R ;
Wu, MJ ;
Lu, JZ ;
Hart, R ;
Hurst, DP ;
Reggio, PH ;
Wiley, JL ;
Martin, BR .
BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (04) :539-549
[8]   DESIGN, SYNTHESIS AND PHARMACOLOGY OF CANNABIMIMETIC INDOLES [J].
HUFFMAN, JW ;
DAI, D ;
MARTIN, BR ;
COMPTON, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (04) :563-566
[9]   Identification of a Cannabinoid Analog as a New Type of Designer Drug in a Herbal Product [J].
Uchiyama, Nahoko ;
Kikura-Hanajiri, Ruri ;
Kawahara, Nobuo ;
Haishima, Yuji ;
Goda, Yukihiro .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2009, 57 (04) :439-441
[10]  
WEISSMAN A, 1982, J PHARMACOL EXP THER, V223, P516